# Endometrial Cancer - LOHP Alone and With 5FU

> **NCT00612495** · PHASE2 · COMPLETED · sponsor: **Sanofi** · enrollment: 31 (actual)

## Conditions studied

- Endometrial Cancer

## Interventions

- **DRUG:** oxaliplatin, 5 FU

## Key facts

- **NCT ID:** NCT00612495
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-01
- **Primary completion:** —
- **Final completion:** 2005-03
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2008-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00612495

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00612495, "Endometrial Cancer - LOHP Alone and With 5FU". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00612495. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*